Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Testosterone gel increases LV mass in older men

Publish date:: January 15, 2020

Key clinical point: Testosterone gel boosts LV mass.

Major finding: Left ventricular mass rose by 3.5% over the course of 1 year of testosterone gel therapy for low testosterone in older men.

Study details: The Testosterone Cardiovascular Trial, a randomized, multicenter, double-blind, placebo-controlled clinical study of 123 older men with andropause.

Disclosures: The presenter reported having no financial conflicts regarding the study, sponsored by the National Institutes of Health.

Citation:

Hutchins E. AHA 2019, session FS.AOS.04.

This Week's Must Reads

Younger adults present with more advanced esophageal adenocarcinoma,

Osteoporosis prevalence in PsA similar to general population,

Annual WCC visits significantly limit asthma worsening,

U.S. mothers underestimate role breastfeeding plays in curbing breast cancer,

Microplastics permeate human placentas,

Must Reads in Cardiology

Sac/val heart failure benefit extends to diabetes patients,

Sedentary postmenopausal women have higher heart failure risk,

Experts disagree with USPSTF’s take on pediatric blood pressure screening,

GALACTIC-HF: New ‘myotropic’ drug class shows modest HFrEF benefit,

Don’t miss cardiovascular risk factors in transgender patients,